Company intelligence / Profile preview

Shanghai Jiangeng Pharmaceutical Technology Co., Ltd.

Shanghai, Shanghai, Chinapharmaceuticalbank.com ↗

Ownership: Private
Development stage: Phase 2

Overview

Shanghai Jiangeng Pharmaceutical Technology Co., Ltd. appears to be an active pharmaceutical technology company based in Minhang District, Shanghai, China. The company maintains a presence at Pujiang High-Tech Park and has been involved with recent trademark activity under the name "TRANSNOVO." No detailed clinical results or product pipeline have been disclosed publicly as of May 2025.

Modalities: small moleculesgeneral pharmaceutical technologies
Industry: Biotech

Drug pipeline

3 assets

ECC5004

Phase 2

Indications: Obesity, Type 2 diabetes

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Shanghai Jiangeng Pharmaceutical Technology Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Jiangeng Pharmaceutical Technology Co., Ltd..

Explore the full profile